Bisphosphonate formulation

Details Bisphosphonate formulation Bisphosphonate formulation

A - Human Necessities

61

K

A61K 47/34 (2006.01) A61K 31/59 (2006.01) A61K 31/663 (2006.01) A61K 31/675 (2006.01) A61P 1/04 (2006.01) A61P 19/10 (2006.01)

Patent

CA 2622322

A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.

L'invention porte sur un bisphosphonate utile dans le traitement de l'ostéoporose et qui est préparé avec une quantité d'un additif antimousse efficace pour réduire la formation de mousse dans l'estomac, et qui entraîne une réduction du reflux et de l'irritation oesophagienne, en utilisation, et permet également une meilleure observance thérapeutique.

Affiliated with

Also associated with

Rating

Bisphosphonate formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bisphosphonate formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonate formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1582602